{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:12:01Z","timestamp":1789726321914,"version":"4.0.1"},"reference-count":23,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T00:00:00Z","timestamp":1122595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> Erosive gastro\u2010oesophageal reflux disease (GERD) is a chronic condition requiring long\u2010term maintenance treatment. However, few trials of proton pump inhibitors in maintaining healing of erosive or ulcerative GERD are conducted for longer than 1\u2003year.<\/jats:p><jats:p><jats:bold>Aim:\u2002<\/jats:bold> To compare the efficacy and safety of 10\u2010 and 20\u2010mg rabeprazole with placebo in the 5\u2010year maintenance of healing in patients previously diagnosed with erosive\/ulcerative GERD healed in an acute efficacy trial.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Patients (<jats:italic>N<\/jats:italic>\u2003=\u2003497) were randomized to receive once\u2010daily doses of 10\u2010 or 20\u2010mg rabeprazole or placebo. The primary efficacy measure was endoscopically documented absence of oesophageal erosions or ulcerations.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> After 5\u2003years, relapse rates in both rabeprazole groups were significantly lower than with placebo (rabeprazole 20\u2003mg, 11%; 10\u2003mg, 23%; placebo, 63%; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001 for rabeprazole vs. placebo; <jats:italic>P<\/jats:italic>\u2003=\u20030.005 for rabeprazole 20\u2003mg vs. 10\u2003mg). Both rabeprazole doses were significantly superior to placebo in preventing relapse of heartburn frequency and improving patient quality of life. Analyses of adverse events, biopsy findings and laboratory values showed no evidence of clinically significant effects.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Five\u2010year maintenance therapy with rabeprazole is effective in preventing relapse of erosive or ulcerative GERD and is well tolerated.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2005.02555.x","type":"journal-article","created":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T18:12:17Z","timestamp":1122660737000},"page":"193-202","source":"Crossref","is-referenced-by-count":45,"title":["Long\u2010term prevention of erosive or ulcerative gastro\u2010oesophageal reflux disease relapse with rabeprazole 10 or 20\u2003mg vs. placebo: results of a 5\u2010year study in the United States"],"prefix":"10.1111","volume":"22","author":[{"given":"A.","family":"CAOS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"BREITER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"PERDOMO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"BARTH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,7,29]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03179.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005468332122"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01303162"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02162.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464030-00004"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01446.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80087-4"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00438.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200917"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01181.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200012080-00008"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90162-X"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70544-5"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70135-1"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00573.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00033.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02214871"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02214874"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199142010-00008"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199754030-00010"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000076372"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.12.001"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655299750025264"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2005.02555.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2005.02555.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:08:43Z","timestamp":1697234923000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2005.02555.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,29]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1111\/j.1365-2036.2005.02555.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02555.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,29]]}}}